JP2014522868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014522868A5 JP2014522868A5 JP2014523080A JP2014523080A JP2014522868A5 JP 2014522868 A5 JP2014522868 A5 JP 2014522868A5 JP 2014523080 A JP2014523080 A JP 2014523080A JP 2014523080 A JP2014523080 A JP 2014523080A JP 2014522868 A5 JP2014522868 A5 JP 2014522868A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation
- protein
- acid sequence
- amino acid
- chimeric cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161513453P | 2011-07-29 | 2011-07-29 | |
| US61/513,453 | 2011-07-29 | ||
| US201261591727P | 2012-01-27 | 2012-01-27 | |
| US61/591,727 | 2012-01-27 | ||
| PCT/US2012/048631 WO2013019652A1 (en) | 2011-07-29 | 2012-07-27 | Purified proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014522868A JP2014522868A (ja) | 2014-09-08 |
| JP2014522868A5 true JP2014522868A5 (https=) | 2015-09-17 |
Family
ID=46682907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014523080A Pending JP2014522868A (ja) | 2011-07-29 | 2012-07-27 | 精製タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20140341843A1 (https=) |
| EP (1) | EP2736524A1 (https=) |
| JP (1) | JP2014522868A (https=) |
| CN (1) | CN104066439A (https=) |
| AU (1) | AU2012290379A1 (https=) |
| BR (1) | BR112014002173A2 (https=) |
| CA (1) | CA2843197A1 (https=) |
| RU (1) | RU2014107743A (https=) |
| SG (1) | SG10201606218WA (https=) |
| WO (1) | WO2013019652A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2952394T3 (es) | 2010-07-29 | 2023-10-31 | Buzzard Pharmaceuticals AB | Antagonistas quiméricos del receptor IL-1 de tipo I |
| EP2968468B1 (en) * | 2013-03-13 | 2021-07-14 | Buzzard Pharmaceuticals AB | Chimeric cytokine formulations for ocular delivery |
| AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| ES2810813T3 (es) * | 2014-01-24 | 2021-03-09 | Am Pharma Bv | Procesamiento para recuperación y purificación de una fosfatasa alcalina |
| WO2015138844A1 (en) * | 2014-03-13 | 2015-09-17 | Eleven Biotherapeutics, Inc. | Methods for production of stable chimeric cytokine protein formulations in blow fill seal containers |
| RU2729161C2 (ru) * | 2014-10-23 | 2020-08-04 | ЭнДжиЭм БАЙОФАРМАСЬЮТИКАЛЗ, ИНК. | Фармацевтические композиции, содержащие варианты пептидов, и способы их применения |
| TW201702380A (zh) * | 2015-02-27 | 2017-01-16 | 再生元醫藥公司 | 宿主細胞蛋白質修飾 |
| CN104710527B (zh) * | 2015-02-28 | 2018-08-24 | 苏州金盟生物技术有限公司 | 一种生物制品的内毒素去除方法 |
| HRP20250718T1 (hr) * | 2016-08-15 | 2025-08-15 | F. Hoffmann-La Roche Ag | Kromatografski postupak za kvantifikaciju neionskog surfaktanta u sastavu koji sadrži neionski surfaktant i polipeptid |
| AU2021262609A1 (en) | 2020-05-01 | 2022-12-22 | Kashiv Biosciences, Llc | An improved process of purification of protein |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| US5693489A (en) | 1984-03-30 | 1997-12-02 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| US4770781A (en) * | 1986-03-03 | 1988-09-13 | Merck & Co., Inc. | Purification of human interleukin-1 species |
| US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
| US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
| US4801686A (en) * | 1986-09-04 | 1989-01-31 | Immunex Corporation | Purification of recombinant interleukin-1 |
| US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
| JP2799483B2 (ja) * | 1988-03-09 | 1998-09-17 | 大塚製薬株式会社 | インターロイキン−１β組成物の安定化方法 |
| AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
| US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
| EP0502956B1 (en) * | 1989-11-29 | 1997-04-23 | Amgen Boulder Inc. | Production of recombinant human interleukin-1 inhibitor |
| ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
| ATE257389T1 (de) * | 1992-09-17 | 2004-01-15 | Amgen Inc | Pharmazeutische zusammensetzungen mit interleukin-1 inhibitoren |
| US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
| PT938501E (pt) * | 1996-06-07 | 2004-11-30 | Aventis Bulk S P A | Processo para a purificacao de um antagonista do receptor de interleucina-1 humana, a partir de e. coli recombinante |
| ES2312179T3 (es) * | 1996-12-06 | 2009-02-16 | Amgen Inc. | Terapia combinada que utiliza un inhibidor del il-1 para el tratamiento de enfermedades mediadas por el il-1. |
| US7083784B2 (en) | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| RS57852B1 (sr) * | 2004-04-02 | 2018-12-31 | Swedish Orphan Biovitrum Ab Publ | Postupci za smanjenje agregacije il-1ra |
| US7700318B2 (en) * | 2004-08-25 | 2010-04-20 | Amprotein Corporation | Chimeric polypeptide and use thereof |
| RU2411957C2 (ru) * | 2004-12-02 | 2011-02-20 | Домантис Лимитед | Способы лечения респираторного заболевания с применением антагонистов рецептора интерлейкина-1 типа 1 |
| SI2173890T1 (sl) | 2007-06-21 | 2011-06-30 | Univ Muenchen Tech | Biološko aktivni proteini, ki imajo povečano in vivo in/ali in vitro stabilnost |
| JP2010536341A (ja) | 2007-08-15 | 2010-12-02 | アムニクス， インコーポレイテッド | 生物学的に活性なポリペプチドの特性を改変するための組成物および方法 |
| WO2011063195A2 (en) * | 2009-11-20 | 2011-05-26 | Dr. Reddy's Laboratories Ltd. | Purification of modified cytokines |
| ES2952394T3 (es) * | 2010-07-29 | 2023-10-31 | Buzzard Pharmaceuticals AB | Antagonistas quiméricos del receptor IL-1 de tipo I |
| WO2012103240A2 (en) * | 2011-01-25 | 2012-08-02 | Eleven Biotherapeutics, Inc. | Receptor binding agents |
-
2012
- 2012-07-27 SG SG10201606218WA patent/SG10201606218WA/en unknown
- 2012-07-27 RU RU2014107743/10A patent/RU2014107743A/ru not_active Application Discontinuation
- 2012-07-27 CA CA2843197A patent/CA2843197A1/en not_active Abandoned
- 2012-07-27 CN CN201280046036.2A patent/CN104066439A/zh active Pending
- 2012-07-27 WO PCT/US2012/048631 patent/WO2013019652A1/en not_active Ceased
- 2012-07-27 US US14/235,777 patent/US20140341843A1/en not_active Abandoned
- 2012-07-27 JP JP2014523080A patent/JP2014522868A/ja active Pending
- 2012-07-27 AU AU2012290379A patent/AU2012290379A1/en not_active Abandoned
- 2012-07-27 BR BR112014002173A patent/BR112014002173A2/pt not_active IP Right Cessation
- 2012-07-27 EP EP12748087.9A patent/EP2736524A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014522868A5 (https=) | ||
| Timmins et al. | Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4 | |
| US8329871B2 (en) | Process of purifying coagulation factor VIII | |
| US7999085B2 (en) | Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers | |
| JP2021508484A5 (https=) | ||
| US20160251636A1 (en) | New methods to produce active tert | |
| JP2010529958A5 (https=) | ||
| RU2014107743A (ru) | Очищенные белки | |
| JP2008054693A (ja) | 酵母宿主から真性のｉｇｆを精製するための方法 | |
| EP3325614A1 (en) | Methods for purifying adenovirus vectors | |
| JP6232130B2 (ja) | ダルベポエチンアルファの精製方法 | |
| JP6861201B2 (ja) | 活性型肝細胞増殖因子（ｈｇｆ）の製造方法 | |
| Liu et al. | TbPIF1, a Trypanosoma brucei mitochondrial DNA helicase, is essential for kinetoplast minicircle replication | |
| US20250215050A1 (en) | Compositions and methods for purifying biological fluids | |
| CA2956316C (en) | Method for purifying antibodies | |
| JPWO2020045473A5 (https=) | ||
| KR102286260B1 (ko) | 설파타아제 단백질을 정제하는 방법 | |
| US9598687B2 (en) | Methods for processing coagulation factors | |
| Balagurunathan et al. | Enhancement of stability of recombinant streptokinase by intracellular expression and single step purification by hydrophobic interaction chromatography | |
| US11919924B1 (en) | Methods of purifying and producing an adalimumab antibody | |
| Rajamanickam et al. | Comparison of Purification Strategies of Three Horseradish PeroxidaseIsoenzymes Recombinantly Produced in Pichia pastoris | |
| EP3239164A2 (en) | Method for purifying target protein | |
| JP5458299B2 (ja) | 甘味誘導物質ミラクリンの精製方法 | |
| JP2001139600A (ja) | Ｉｌ−６ｒ・ｉｌ−６融合蛋白質の精製方法 | |
| JP2013153770A (ja) | 組換え体ヒトｆｓｈの製造方法 |